Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study-Reference-Cited by-同舟云学术

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

Published:2023-04 Issue:4 Volume:10 Page:e254-e265
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Smith Jennifer,Bansi-Matharu Loveleen,Cambiano Valentina,Dimitrov Dobromir,Bershteyn Anna,van de Vijver David,Kripke Katharine,Revill Paul,Boily Marie-Claude,Meyer-Rath Gesine,Taramusi Isaac,Lundgren Jens D,van Oosterhout Joep J,Kuritzkes Daniel,Schaefer Robin,Siedner Mark J,Schapiro Jonathan,Delany-Moretlwe Sinead,Landovitz Raphael J,Flexner Charles,Jordan Michael,Venter Francois,Radebe Mopo,Ripin David,Jenkins Sarah,Resar Danielle,Amole Carolyn,Shahmanesh Maryam,Gupta Ravindra K,Raizes Elliot,Johnson Cheryl,Inzaule Seth,Shafer Robert,Warren Mitchell,Stansfield Sarah,Paredes Roger,Phillips Andrew N

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference34 articles.

1. Oral preexposure prophylaxis continuation, measurement, and reporting;Stankevitz;AIDS,2020

2. Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in east Africa;Heffron;Gates Open Res,2018

3. 2019. The invisible product: preferences for sustained-release, long-acting pre-exposure prophylaxis to HIV among south African youth;Montgomery;J Acquir Immune Defic Syndr,2019

4. Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland;Siedner;AIDS,2018

5. Cabotegravir for HIV prevention in cisgender men and transgender women;Landovitz;N Engl J Med,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations;International Journal of Antimicrobial Agents;2024-09

2. HIV Pre-Exposure Prophylaxis;Infectious Disease Clinics of North America;2024-09

3. Health and budget impact, and price threshold for cost-effectiveness of lenacapavir for PrEP in Eastern and Southern Africa: a modeling analysis;2024-08-21

4. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

5. The long wait for long-acting HIV prevention and treatment formulations;The Lancet HIV;2024-08